BioSpace News Archive

She will replace Gordon Naylor, who announced his retirement earlier this year.

The webcast can be accessed live on the Investor Relations section of the Company’s website at http://investors.portola.com.

Field’s unique approach is a combination of cutting-edge, FDA-approved techniques to optimize clients’ brain function and performance.

Erchonia received FDA clearance after submitting results from double-blind and placebo-controlled clinical trials with 255 patients

Mindfulness training research done at RMIT University in Melbourne confirms that mindfulness practitioners benefit greatly from the immersive nature of Atmosphaeres’ 360° VR Experiences, particularly if they wish to improve their decentring skills

Presentation will focus on recovery of a patient with left hemiparesis post-right MCA infarction

Eagle Telemedicine announced today that its Chief Medical Officer, Jayne Lee, MD, received the Founder’s Award for Telehealth Excellence at InTouch Health’s 13th Telehealth Innovation Forum in Santa Barbara, Calif.

Huntsworth PLC (LSE: HNT) (www.huntsworth.com), an international healthcare and communications group, announced the appointment of Helen Apostolidis to the position of Chief Talent Officer (CTO).

DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged that the submission of DURECT’s full response to the Complete Response Letter (CRL) it previously received from FDA related to POSIMIR® (bupivacaine extended-release solution) is considered by the FDA to be a complete class 2 response to the CRL

Over 50 screening days planned in six countries